Warrington, PA – Polysciences, Inc., an award-winning company specializing in the development and manufacture of high purity chemicals and reagents for laboratory research, announced the appointment of Kimberly Glover as new Product Manager of its Life Sciences Division. In this role, Ms. Glover will assume responsibility of Polysciences’ Life Sciences product lines, including; histology, light […]
Franklin Lakes, N.J. — BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced the election of Dr. Claire Pomeroy to its Board of Directors. Dr. Pomeroy, 58, is an expert in infectious diseases and a long-time advocate for public health and patients, especially those with HIV/AIDS. She is currently President of […]
SAN DIEGO — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced a resolution of litigation between the Company and Paul Hawran. Mr. Hawran served as the Company’s Chief Financial Officer from April 2007 until September 2009. Mr. Hawran resigned in September 2009. After September 2009, […]
Beijing, China, and Hilden, Germany — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the commercial launch in China of its QuantiFERON®-TB Gold In-Tube (QuantiFERON-TB), the pioneering blood test that accurately identifies people infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB). QuantiFERON-TB has become the test of choice around the world […]
Salt Lake City, UT — BioFire Defense, LLC of Salt Lake City, UT announced today that it was awarded the Next Generation Diagnostic System (NGDS) Technology Development contract by the US Department of Defense (DoD) after 12 months of competitive prototyping. The 8 year $240M biodefense program is managed by the Joint Program Executive Office’s […]
OMAHA, Neb.– Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced the appointment of Michael A. Luther, Ph.D., to its Board of Directors. Dr. Luther will also become a member of the Board’s audit committee. […]
PAISLEY, United Kingdom–(BUSINESS WIRE)–Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has completed the acquisition of Prionics AG, a privately held animal health diagnostics company. Founded in 1997, Prionics is headquartered in Zurich, Switzerland, and has a major production facility in Lelystad, the Netherlands. Prionics’ product line of more than […]
CAMBRIDGE, Mass. – Good Start Genetics®, Inc., an innovative molecular genetic information company, today announced a strategic agreement with PerkinElmer, Inc. (NYSE:PKI) to expand access to GoodStart Select™ genetic carrier screening tests beyond the in vitro fertilization (IVF) setting to the broader women’s health community, including obstetrics and gynecology (OBGYN) and maternal fetal medicine (MFM) […]
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced a strategic agreement with Good Start Genetics®, Inc. to expand access to GoodStart Select™ genetic carrier screening tests beyond the in vitro fertilization (IVF) setting the broader women’s health community — including obstetrics and gynecology (OBGYN) and […]
Sysmex Enters into Clinical Research, Joint Development and Licensing Agreement with Merck Millipore
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has entered into a clinical research, joint development and licensing agreement with Merck Millipore (HQ: Massachusetts, United States) involving Merck Millipore imaging flow cytometry technology. The aim of this collaboration is to use Merck Millipore’s flow cytometry technology as a platform to accelerate the creation […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
